Article Details

Pfizer beats Sarepta to the start of first late-stage Duchenne gene therapy trial

Retrieved on: 2021-01-07 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

Pfizer beats Sarepta to the start of first late-stage Duchenne gene therapy trial. View article details on hiswai:

Excerpt

The boy, who received his infusion of Pfizer's gene therapy on Dec. 29 at a study site in Barcelona, Spain, is the first Duchenne patient to receive a gene ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up